ArticleEuropean heart journal2017
Limitations of the SCORE-guided European guidelines on cardiovascular disease prevention.
Article in European heart journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies.European heart journal · 2019Pooled it
- Review
- Personalized Treatment of Patients with Coronary Artery Disease: The Value and Limitations of Predictive Models.Journal of cardiovascular development and disease · 2025Review
- Article
- Evolving Concepts of the SCORE System: Subtracting Cholesterol from Risk Estimation: A Way for a Healthy Longevity?Life (Basel, Switzerland) · 2024Review
- A cost-effectiveness evaluation of a high-sensitivity troponin I guided voluntary cardiovascular risk assessment program for asymptomatic women in Croatia.International journal of cardiology. Cardiovascular risk and prevention · 2024Article
- Article
- Subendocardial Viability Ratio Predictive Value for Cardiovascular Risk in Hypertensive Patients.Medicina (Kaunas, Lithuania) · 2022Article
- Targeting a Silent Disease: Vascular Calcification in Chronic Kidney Disease.International journal of molecular sciences · 2022Review
- Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines.JAMA cardiology · 2022Article
- Cardiovascular Risk Prediction Models and Scores in the Era of Personalized Medicine.Journal of personalized medicine · 2022Review
- Estimating the cost-effectiveness of screening a general population for cardiovascular risk with high-sensitivity troponin-I.European heart journal. Quality of care & clinical outcomes · 2022Article
- Large health disparities in cardiovascular death in men and women, by ethnicity and socioeconomic status in an urban based population cohort.EClinicalMedicine · 2021Article
- Understanding providers' attitudes and key concerns toward incorporating CVD risk prediction into clinical practice: a qualitative study.BMC health services research · 2021Article
- Associations Between Systolic Interarm Differences in Blood Pressure and Cardiovascular Disease Outcomes and Mortality: Individual Participant Data Meta-Analysis, Development and Validation of a Prognostic Algorithm: The INTERPRESS-IPD Collaboration.Hypertension (Dallas, Tex. : 1979) · 2021Article
- Epidemiology and pathophysiologic insights of coronary atherosclerosis relevant for contemporary non-invasive imaging.Cardiovascular diagnosis and therapy · 2020Review
- Low-density lipoprotein cholesterol lowering treatment: the current approach.Lipids in health and disease · 2020Review
- Performance of risk prediction scores for cardiovascular mortality in older persons: External validation of the SCORE OP and appraisal.PloS one · 2020Article
- Economic Evaluation of the 2016 Chinese Guideline and Alternative Risk Thresholds of Initiating Statin Therapy for the Management of Atherosclerotic Cardiovascular Disease.PharmacoEconomics · 2019Article
- Agreement of PROCAM and SCORE to assess cardiovascular risk in two different low risk European populations.Preventive medicine reports · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.